(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 19.7% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.13%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.55%.
Glaukos's revenue in 2025 is $432,953,000.On average, 9 Wall Street analysts forecast GKOS's revenue for 2025 to be $27,767,257,906, with the lowest GKOS revenue forecast at $27,640,973,234, and the highest GKOS revenue forecast at $27,949,516,164. On average, 9 Wall Street analysts forecast GKOS's revenue for 2026 to be $35,235,430,563, with the lowest GKOS revenue forecast at $34,366,406,210, and the highest GKOS revenue forecast at $36,209,634,792.
In 2027, GKOS is forecast to generate $43,767,732,229 in revenue, with the lowest revenue forecast at $42,492,325,868 and the highest revenue forecast at $47,056,237,833.